We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CMXHF market cap is 96.65B. The company's latest EPS is USD 4.5401 and P/E is 66.03.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 8.51B | 9.1B | 10.27B | 10.49B | 13.17B |
| Operating Income | 2.52B | 2.72B | 3.13B | 2.93B | 3.07B |
| Net Income | 1.92B | 2.1B | 2.38B | 2.25B | 2.19B |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 12.31B | 15.62B | 18.16B | 28.35B | 36.23B |
| Total Liabilities | 7.06B | 9.09B | 9.78B | 13.77B | 18.41B |
| Total Equity | 5.25B | 6.53B | 8.38B | 14.58B | 17.83B |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.64B | 2.49B | 3.62B | 2.63B | 2.6B |
| Investing | -1.29B | -1.37B | -1.67B | -1.64B | -11.84B |
| Financing | -491.5M | -642.7M | -1.4B | 7.68B | 456M |
| Market Cap | 96.65B |
| Price to Earnings Ratio | 66.03 |
| Price to Sales Ratio | 11 |
| Price to Cash Ratio | 93.59 |
| Price to Book Ratio | 8.13 |
| Dividend Yield | 1.24% |
| Shares Outstanding | 483.25M |
| Average Volume (1 week) | 579 |
| Average Volume (1 Month) | 881 |
| 52 Week Change | 13.46% |
| 52 Week High | 201.25 |
| 52 Week Low | 144.81 |
| Spread (Intraday) | 9.49 (4.65%) |
| Company Name | Csl Ltd (QX) |
| Address |
45 poplar road melbourne, victoria 3052 |
| Website | https://www.csl.com.au |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
